Castle Creek Biosciences is a late-clinical stage regenerative medicine company focused on severe skin and connective tissue disorders. It is launching a pivotal clinical trial for patients with dystrophic epidermolysis bullosa (DEB).
Company Details
- Employees
- 36
- Founded
- 2020
- Address
- 405 Eagleview Blvd, Exton,pennsylvania 19341,united States
- Phone
- (484) 713-6133
- co****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- castlecreekbio.com
- Keywords
- Gene therapy, Rare disease, Clinical research, Drug development, Dermatology, Epidermolysis Bullosa, Life sciences, Personalized medicine, Biotechnology, Genetics, Orphan drug, Pediatric disease, Bioscience.
- HQ
- Exton, Pennsylvania
Castle Creek Biosciences, Inc. Questions
Castle Creek Biosciences, Inc.'s helpline number is (484) 713-6133
Castle Creek Biosciences, Inc.'s website is castlecreekbio.com
Castle Creek Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/castlecreekbio
Castle Creek Biosciences, Inc. has
36 employees.
View email and phone details for 36
employees at Castle Creek Biosciences, Inc..
Castle Creek Biosciences, Inc.'s industry is
Biotechnology Research
Castle Creek Biosciences, Inc.'s top competitors are
Evozyne,
Emalex Biosciences,
Circ Biosciences,
Castle Biosciences, Inc.,
Abeona Therapeutics,
Rocket Pharmaceuticals,
Ligand Pharmaceuticals,
Harmony Biosciences,
Paragon Biosciences,
Grove Biopharma, Inc..
Castle Creek Biosciences, Inc.'s support email address is contact@castlecreekpharma.com
Castle Creek Biosciences, Inc.'s categories are Biotechnology Research
Castle Creek Biosciences, Inc.'s founding year is 2020
